|
The tracks for Biotech 2008 are listed below.
| Communications |
|
|
| Drug Delivery, Device, and Diagnostics |
- Drug Delivery Technologies: What's Old is New (and better) through Drug Delivery
- Drug-Device Combinations: Symbiosis and Synergy
- On the Cutting Edge - The Future of Medical Devices
|
| Finance |
- Collaboration: The Current State of Funding
- The Evolution of Capital: Traditional and Non-Traditional Funding
- Strategic Transactions - The Evolving Convergence of the Biotech and Pharma Industries
|
| Growth Strategies for Bioscience Companies |
- Licensing Discussions Morphing into an M&A Deal - Is This a Viable Option for You?
- Developing Your Pipeline While Minimizing Risk and Managing a Great Exit
- Strategic Crossroads: Buy, Build, or Partner for Commercialization Capabilities
|
| Hot Topics in Business |
- Building and Sustaining a Fundable Management Team
- Developing a Successful Reimbursement Strategy
- Dealmaking and Strategic Partnerships that Create Value
|
| Hot Topics in Science |
- Antibacterial Drug Resistance: Challenges and Advances
- Beyond Monoclonal Antibodies - Novel Constructs Take the Stage
- The Use of Biomarkers in Clinical Trials: Isn't it Time for 21st Century Medicine?
|
| Regulatory |
- Recent FDA Regulatory Legislation and How it Affects Your Company
- Global Submissions and Implications: Managing a Multi-National Phase 2 or Phase 3 Clinical Study
- How to Position Effectively Your Biotech Company for Upcoming Regulatory Compliance Issues
|
|
